Silvercrest Asset Management’s Pediatrix Medical MD Stock Holding History

Silvercrest Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.8M	Sell	970,610 -61,741	-6%	-$1.29M	0.15%	183
2025 Q4	$22.1M	Buy	+1,032,351	New	+$21.2M	0.15%	182
2017 Q1	–	Sell	-4,390	Closed	-$293K	–	586
2016 Q4	$293K	Hold	4,390	–	–	﹤0.01%	489
2016 Q3	$291K	Hold	4,390	–	–	﹤0.01%	472
2016 Q2	$318K	Hold	4,390	–	–	﹤0.01%	468
2016 Q1	$283K	Hold	4,390	–	–	﹤0.01%	470
2015 Q4	$315K	Hold	4,390	–	–	﹤0.01%	477
2015 Q3	$337K	Sell	4,390 -2,000	-31%	-$161K	0.01%	407
2015 Q2	$474K	Buy	6,390 +390	+7%	+$28.1K	0.01%	405
2015 Q1	$435K	Hold	6,000	–	–	0.01%	383
2014 Q4	$397K	Hold	6,000	–	–	0.01%	385
2014 Q3	$329K	Hold	6,000	–	–	0.01%	395
2014 Q2	$349K	Hold	6,000	–	–	0.01%	393
2014 Q1	$372K	Hold	6,000	–	–	0.01%	372
2013 Q4	$320K	Hold	6,000	–	–	0.01%	387
2013 Q3	$301K	Hold	6,000	–	–	0.01%	384
2013 Q2	$275K	Buy	+6,000	New	+$269K	0.01%	383

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Silvercrest Asset Management's MD Position: Q1 2026 in Review

Silvercrest Asset Management reduced its Pediatrix Medical (MD) stake by 6% in Q1 2026, selling an estimated $1.29M and leaving 970,610 shares worth $20.8M. The position accounts for 0.15% of the portfolio, ranked #183.

Silvercrest Asset Management first reported a position in MD in Q2 2013 and has held it in 17 quarters since. The position peaked at $22.1M in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Silvercrest Asset Management held 970,610 shares of Pediatrix Medical worth $20.8M as of Q1 2026.
Silvercrest Asset Management sold 61,741 Pediatrix Medical shares in Q1 2026, an estimated $1.29M.
Pediatrix Medical made up 0.15% of Silvercrest Asset Management's portfolio in Q1 2026, its #183 holding.
Silvercrest Asset Management first reported a position in Pediatrix Medical in Q2 2013 and has held it in 17 quarters since.
Silvercrest Asset Management's Pediatrix Medical position peaked at $22.1M in Q4 2025.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.